Annexin 1: more than an anti-phospholipase protein
- PMID: 15060718
- DOI: 10.1007/s00011-003-1235-z
Annexin 1: more than an anti-phospholipase protein
Abstract
Annexin 1 (ANXA1) is the first characterized member of the annexin family of proteins able to bind (i.e. to annex) to cellular membranes in a calcium-dependent manner. ANXA1 may be induced by glucocorticoids in inflammatory cells and shares with these drugs many anti-inflammatory effects. Originally described as a phospholipase A2 (PLA2)-inhibitory protein, ANXA1 can affect many components of the inflammatory reaction besides the metabolism of arachidonic acid. Recent data have shown that ANXA1 may specifically target cytosolic PLA2 by both direct enzyme inhibition and suppression of cytokine-induced activation of the enzyme. ANXA1 inhibits the expression and/or activity of other inflammatory enzymes like inducible nitric oxide synthase (iNOS) in macrophages and inducible cyclooxygenase (COX-2) in activated microglia. The inhibition of iNOS expression may be caused by the stimulation of IL-10 release induced by ANXA1 in macrophages. Like glucocorticoids, ANXA1 exerts profound inhibitory effects on both neutrophil and monocyte migration in inflammation. Several mechanisms may contribute to the protein effect on cell migration, namely the activation of receptors like the formyl peptide receptor (FPR) and the lipoxin A4 receptor (ALXR), the shedding of L-selectin, the binding to alpha4beta1 integrin and carboxylated N-glycans. Furthermore, again mimicking the action of glucocorticoids, ANXA1 promotes inflammatory cell apoptosis associated with transient rise in intracellular calcium and caspase-3 activation. Finally, ANXA1 has been recently identified as one of the 'eat-me' signals on apoptotic cells to be recognised and ingested by phagocytes. Thus, ANXA1 may contribute to the anti-inflammatory signalling that allows safe post-apoptotic clearance of dead cells.
Similar articles
-
Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis.Int Immunopharmacol. 2003 Oct;3(10-11):1363-9. doi: 10.1016/S1567-5769(03)00133-4. Int Immunopharmacol. 2003. PMID: 12946433
-
Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.J Immunol. 2013 Jun 1;190(11):5689-701. doi: 10.4049/jimmunol.1202030. Epub 2013 May 3. J Immunol. 2013. PMID: 23645879
-
Differential modulatory effects of annexin 1 on nitric oxide synthase induction by lipopolysaccharide in macrophages.Immunology. 2006 Mar;117(3):340-9. doi: 10.1111/j.1365-2567.2005.02307.x. Immunology. 2006. PMID: 16476053 Free PMC article.
-
New mechanisms for effects of anti-inflammatory glucocorticoids.Biofactors. 1991 Jun;3(2):97-102. Biofactors. 1991. PMID: 1832865 Review.
-
Topical glucocorticoids and the skin--mechanisms of action: an update.Mediators Inflamm. 1998;7(3):183-93. doi: 10.1080/09629359891126. Mediators Inflamm. 1998. PMID: 9705606 Free PMC article. Review.
Cited by
-
CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features.Mol Cancer Res. 2014 Apr;12(4):607-21. doi: 10.1158/1541-7786.MCR-13-0469. Epub 2014 Jan 24. Mol Cancer Res. 2014. PMID: 24464914 Free PMC article.
-
Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA).Cell Signal. 2008 May;20(5):844-61. doi: 10.1016/j.cellsig.2008.01.004. Epub 2008 Jan 17. Cell Signal. 2008. PMID: 18291623 Free PMC article.
-
The role of NFκB in spheroid formation of human breast cancer cells cultured on the Random Positioning Machine.Sci Rep. 2018 Jan 17;8(1):921. doi: 10.1038/s41598-017-18556-8. Sci Rep. 2018. PMID: 29343717 Free PMC article.
-
The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.J Neuroinflammation. 2016 Sep 2;13(1):234. doi: 10.1186/s12974-016-0692-6. J Neuroinflammation. 2016. PMID: 27590054 Free PMC article.
-
Glucocorticoid-stimulated, transcription-independent release of annexin A1 by cochlear Hensen cells.Br J Pharmacol. 2009 Dec;158(7):1820-34. doi: 10.1111/j.1476-5381.2009.00473.x. Br J Pharmacol. 2009. PMID: 19912231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous